66. Yakoumakis E, Tsalafoutas IA, Nikolaou D i sur. Differences in effective doseestimation from dose-area product and entrancesurface dose measurements inintravenous urography. Br J Radiol 2001;74(884):727–34.67. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survivalduring the last 2 decades. J Urol 2000;164:1523–5.68. Kawashima A, Glockner JF, King BF Jr. <strong>CT</strong> urography and MR urography. RadiolClin North Am 2003;41:945–61.69. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the kidney, bladder, and relatedurinary structures. Washington, DC: American Registry of Pathology, 2004; 394.70. Wong-You–Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. Neoplasms ofthe Urinary Bladder: Radiologic-Pathologic Correlation. RadioGraphics 2006;26:553–80.71. Cancer facts and figures 2005 (baza podataka). American Cancer Society Web stranica72. Surveillance, Epidemiology, and End Results (SEER) Program, SEER*Stat DatabaseIncidence—SEER 9 Regs Public-Use. Bethesda, Md: National Cancer Institute,Division of Cancer Control and Population Sciences, Surveillance Research Program,Cancer Statistics Branch, 200473. Montironi R, Lopez-Beltran A. The 2004 WHO classification of bladder tumors: asummary and commentary. Int J Surg Pathol 2005;13:143–53.74. Tekes A, Kamel IR, Imam K i sur. MR imaging features of transitional cell carcinomaof the urinary bladder. AJR Am J Roentgenol 2003;180:771–7.75. Sutton JM. Evaluation of haematuria in adults. JAMA 1990;263:2475–80.76. Moon WK, Kim SH, Cho JM i sur. Calcified bladder tumors: <strong>CT</strong> features. Acta Radiol1992; 33:440–3.77. Kim JK, Park SY, Ahn HJ i sur. Bladder cancer: analysis of multi-detector row helical<strong>CT</strong> enhancement pattern and accuracy in tumor detection and perivesical staging.Radiology 2004;231:725–73.93
78. Barentsz JO, Witjes JA, Ruijs JH. What is new in bladder cancer imaging. Urol ClinNorth Am 1997;24:583–602.79. Tekes A, Kamel I, Imam K i sur. Dynamic MRI of bladder cancer: evaluation ofstaging accuracy. AJR Am J Roentgenol 2005;184:121–7.80. Barentsz JO, Engelbrecht M, Jager GJ i sur. Fast dynamic gadolinium-enhanced MRimaging of urinary bladder and prostate cancer. J Magn Reson Imaging 1999;10:295–304.81. Deserno WM, Harisinghani MG, Taupitz M i sur. Urinary bladder cancer:preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology2004;233:449–56..82. Knoxa M K, Cowan N C, Rivers-Bowerman M D, Turney B W. Evaluation ofmultidetector computed tomography urography and ultrasonography for diagnosingbladder cancer. Clinical Radiology 2008;63:1317-25.83. Song JH, Francis IR, Platt JF i sur. Bladder tumor detection at virtual cystoscopy.Radiology 2001;218:95–100.84. Dey P. Urinary markers of bladder carcinoma. Clin Chim Acta 2004;340:57–65.85. Jinzaki M, Tanimoto A, Shinmoto H i sur. Detection of bladder tumors with dynamiccontrast-enhanced MD<strong>CT</strong>. AJR Am J Roentgenol 2007;188:913.86. Eble JN, Sauter G, Epstein JI, Sesterhenn IA ur. Pathology and genetics of tumours ofthe urinary system and male genital organs. Lyon: IARC Press, 2004.87. Lane BR, Kattan MW. Predicting outcomes in renal cell carcinoma. Curr Opin Urol2005;15: 289–97.88. Cheng WS, Farrow GM, Zincke H. The incidence of multicentricity in renal cellcarcinoma. J Urol 1991;146:1221–3.89. Jinzaki M, Tanimoto A, Mukai M i sur. Doublephase helical <strong>CT</strong> of small renalparenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis.J Comput Assist Tomogr 2000;24:835–42.94
- Page 1 and 2:
Središnja medicinska knjižnicaĆu
- Page 3 and 4:
Disertacija je izrađena na Zavodu
- Page 5 and 6:
SADRŽAJ1. POPIS OZNAKA I KRATICA..
- Page 7:
1. POPIS OZNAKA I KRATICABMI-body m
- Page 11 and 12:
kontrasta (26,27). Treća faza je e
- Page 13 and 14:
dok je na aksijalnim slojevima otkr
- Page 15 and 16:
hidrirani prije CTU u odnosu na gru
- Page 17 and 18:
primjenjiv i kod ostalih protokola.
- Page 19 and 20:
Dvije osnovne tehnike izvođenja MR
- Page 21 and 22:
tumorima urotrakta ili o invaziji u
- Page 23 and 24:
Ureteroskopijom i cistoskopijom dob
- Page 25 and 26:
Tuberkuloza urotrakta u pravilu nas
- Page 27 and 28:
značajno niža, a IV urografijom n
- Page 29 and 30:
smrtnost veća. Petogodišnje prež
- Page 31 and 32:
CTU je u tome što omogućuje procj
- Page 33 and 34:
cistoskopiju u svim osim u dvojbeni
- Page 35 and 36:
CT-u su obično izo ili hipodenznij
- Page 37 and 38:
krvarenja. Hipovaskularni su na DSA
- Page 39 and 40:
2.7.4. Policistični bubreziMultipl
- Page 41 and 42:
3cm u promjeru< 1/3 ciste izvan kon
- Page 43 and 44: funkcionalan odnosno dolazi do tzv
- Page 45 and 46: čine celularni detritus, krv i bak
- Page 47 and 48: 3. HIPOTEZE I CILJEVI ISTRAŽIVANJA
- Page 49 and 50: faktorom za određeni organ prema I
- Page 51 and 52: isključeno iz studije zbog hidrone
- Page 53 and 54: Slika 1. Na VRT rekonstrukciji se p
- Page 55 and 56: Slika 3. Na aksijalnom presjeku i s
- Page 57 and 58: U skupini bolesnika koja je hidrira
- Page 59 and 60: skupini bolesnika koji su hidrirani
- Page 61 and 62: Skupina Nekompletan prikaz Kompleta
- Page 63 and 64: Graf 3Graf 4Grafovi 3 i 4 Broj komp
- Page 65 and 66: Graf 7Graf 8Grafovi 7 i 8. Broj kom
- Page 67 and 68: Graf 11Graf 12Grafovi 11 i 12. Broj
- Page 69 and 70: Da bi se ispitao utjecaj ispunjenos
- Page 71 and 72: Tablica 20. Doze zračenja na pojed
- Page 73 and 74: daje dovoljno vremena za odgovaraju
- Page 75 and 76: što boljeg prikaza urotrakta. Opis
- Page 77 and 78: stupanj ispunjenosti uretera i opac
- Page 79 and 80: otopine u skupini bolesnika kojoj j
- Page 81 and 82: više snimanja u ekskrecijskoj fazi
- Page 83 and 84: 7. ZAKLJUČCIOralna hidracija boles
- Page 85 and 86: skupine bolesnika (p
- Page 87 and 88: patients given oral hydration 20 mi
- Page 89 and 90: 11. Fritz GA, Schoelnast H, Deutsch
- Page 91 and 92: 33. Chow LC, Kwan SW, Olcott EW i s
- Page 93: 54. Roy C, Saussine C, LeBras Y. As
- Page 97 and 98: 102. Prokop M, Galanski M, Schaefer